Management of subglottic hemangiomas with carbon dioxide laser: Our 25-year experience and comparison with the literature.

Related Articles

Management of subglottic hemangiomas with carbon dioxide laser: Our 25-year experience and comparison with the literature.

Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2003-7

Authors: Clarós A, Fokouo JV, Roqueta C, Clarós P

Abstract
INTRODUCTION: Subglottic hemangiomas (SGH) are rare tumors of infancy arising between the perichondrium and the mucosa of the subglottic space. It is a potential life-threatening condition. Many therapeutic options exist for this disease, including lasers.
OBJECTIVE: To report our 25-year experience of laser treatment of SGH.
MATERIAL AND METHODS: Retrospective review of charts.
SETTING: Clarós' Otolaryngology and Head and Neck Surgery Clinic in Barcelona, Spain.
RESULTS: We recruited a total of 97 patients of whom 89 were treated with CO2 laser. Mean age at first contact was 2.1 months (range: 1.5-6.5). Sex ratio was 10 girls for 1 boy. Eighty percent of patients presented with stridor and 30.3% with recurrent acute laryngitis. Forty percent had associated cutaneous hemangiomas. They received an average of 1.85 laser session (range: 1-4) and 78.5% were healed after a maximum of 2. We had a 100% success rate and 1.1% complication rate (subglottic stenosis).
CONCLUSION: CO2 laser is a very effective and recommendable tool against subglottic hemangiomas. To achieve good results traditional laser safety measures should be respected besides some useful surgical tips.

PMID: 26614224 [PubMed - indexed for MEDLINE]

from #ENT-PubMed via ola Kala on Inoreader http://ift.tt/1lnPscI
via IFTTT